免疫抑制药物地塞米松在艰难梭菌感染期间与胃肠道微生物群转移相关的有害作用。
A Detrimental Role of Immunosuppressive Drug, Dexamethasone, During Clostridium difficile Infection in Association with a Gastrointestinal Microbial Shift.
作者信息
Kim Hyeun Bum, Wang Yuankai, Sun Xingmin
机构信息
Department of Infectious Disease and Global Health, Tufts University, North Grafton, MA 01536, USA.
Department of Animal Resource and Science, Dankook University, Cheonan, Chungnam 31116, Republic of Korea.
出版信息
J Microbiol Biotechnol. 2016 Mar;26(3):567-71. doi: 10.4014/jmb.1512.12017.
Abstract
We investigated the increased risk of Clostridium difficile infection (CDI) caused by the combined use of antibiotics and an immunosuppressive drug in a mouse model. Our data showed that an approximate return to pretreatment conditions of gut microbiota occurred within days after cessation of the antibiotic treatment, whereas the recovery of gut microbiota was delayed with the combined treatment of antibiotics and dexamethasone, leading to an increased severity of CDI. An alteration of gut microbiota is a key player in CDI. Therefore, our data implied that immunosuppressive drugs can increase the risk of CDI through the delayed recovery of altered gut microbiota.
摘要
我们在小鼠模型中研究了抗生素与免疫抑制药物联合使用导致艰难梭菌感染（CDI）风险增加的情况。我们的数据表明，抗生素治疗停止后数天内，肠道微生物群的情况大致恢复到治疗前状态，而抗生素与地塞米松联合治疗时，肠道微生物群的恢复则延迟，导致CDI严重程度增加。肠道微生物群的改变是CDI的关键因素。因此，我们的数据表明免疫抑制药物可通过延迟改变的肠道微生物群的恢复来增加CDI风险。
相似文献
1
A Detrimental Role of Immunosuppressive Drug, Dexamethasone, During Clostridium difficile Infection in Association with a Gastrointestinal Microbial Shift.免疫抑制药物地塞米松在艰难梭菌感染期间与胃肠道微生物群转移相关的有害作用。
J Microbiol Biotechnol. 2016 Mar;26(3):567-71. doi: 10.4014/jmb.1512.12017.
2
Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.口腔 fidaxomicin 给药对小鼠肠道微生物群和艰难梭菌定植易感性的影响。
Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.02112-17. Print 2018 May.
3
The role of zinc and nutritional immunity in Clostridium difficile infection.锌和营养免疫在艰难梭菌感染中的作用。
Gut Microbes. 2018;9(5):469-476. doi: 10.1080/19490976.2018.1448354. Epub 2018 Sep 25.
4
The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with Infection.单克隆抗毒素抗体（Actoxumab-Bezlotoxumab）治疗有助于感染小鼠肠道微生物群的正常化。
Front Cell Infect Microbiol. 2016 Oct 4;6:119. doi: 10.3389/fcimb.2016.00119. eCollection 2016.
5
Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.艰难梭菌感染和无症状艰难梭菌定植中肠道微生物群变化的见解。
Anaerobe. 2015 Aug;34:1-7. doi: 10.1016/j.anaerobe.2015.03.008. Epub 2015 Mar 26.
6
Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin.艰难梭菌感染啮齿动物模型中的疾病进展与消退以及抗毒素抗体和万古霉素的影响
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6471-6482. doi: 10.1128/AAC.00974-16. Print 2016 Nov.
7
Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human Colon.奥马环素对肠道微生物组的暴露在模拟人体近端、中段和远端结肠的模型中不会引起艰难梭菌的增殖或毒素产生。
Antimicrob Agents Chemother. 2019 Jan 29;63(2). doi: 10.1128/AAC.01581-18. Print 2019 Feb.
8
Nonantimicrobial drug targets for Clostridium difficile infections.艰难梭菌感染的非抗菌药物靶点
Future Microbiol. 2017 Sep;12(11):975-985. doi: 10.2217/fmb-2017-0024. Epub 2017 Jul 31.
9
Analysis of Bacterial Communities during Clostridium difficile Infection in the Mouse.艰难梭菌感染小鼠过程中细菌群落的分析。
Infect Immun. 2015 Nov;83(11):4383-91. doi: 10.1128/IAI.00145-15. Epub 2015 Aug 31.
10
Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection.评估 NVB302 与万古霉素在体外艰难梭菌感染人类肠道模型中的活性。
J Antimicrob Chemother. 2013 Jan;68(1):168-76. doi: 10.1093/jac/dks359. Epub 2012 Sep 10.
引用本文的文献
1
Gut Microbiome in Patients after Heart Transplantation-Current State of Knowledge.心脏移植术后患者的肠道微生物群——当前的知识状况
Biomedicines. 2023 May 30;11(6):1588. doi: 10.3390/biomedicines11061588.
2
Association Between Immunosuppressive Therapy and Outcome of Clostridioides difficile Infection: Systematic Review and Meta-Analysis.免疫抑制治疗与艰难梭菌感染结局的关系：系统评价和荟萃分析。
Dig Dis Sci. 2022 Aug;67(8):3890-3903. doi: 10.1007/s10620-021-07229-2. Epub 2021 Sep 23.
3
Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.门诊环境中艰难梭菌叠加感染对克罗恩病或溃疡性结肠炎发作的影响。
Int J Colorectal Dis. 2018 Sep;33(9):1285-1294. doi: 10.1007/s00384-018-3105-8. Epub 2018 Jun 21.
4
Biology: Sporulation, Germination, and Corresponding Therapies for Infection.生物学：孢子形成、发芽和相应的感染治疗。
Front Cell Infect Microbiol. 2018 Feb 8;8:29. doi: 10.3389/fcimb.2018.00029. eCollection 2018.
5
Blueberry Phenolics Reduce Gastrointestinal Infection of Patients with Cerebral Venous Thrombosis by Improving Depressant-Induced Autoimmune Disorder via miR-155-Mediated Brain-Derived Neurotrophic Factor.蓝莓酚类物质通过miR-155介导的脑源性神经营养因子改善抑郁诱导的自身免疫紊乱，从而减少脑静脉血栓形成患者的胃肠道感染。
Front Pharmacol. 2017 Nov 27;8:853. doi: 10.3389/fphar.2017.00853. eCollection 2017.
6
Molecular, microbiological and clinical characterization of Clostridium difficile isolates from tertiary care hospitals in Colombia.来自哥伦比亚三级护理医院的艰难梭菌分离株的分子、微生物学及临床特征
PLoS One. 2017 Sep 13;12(9):e0184689. doi: 10.1371/journal.pone.0184689. eCollection 2017.
7
Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent Infection in a Pediatric Heart Transplant Patient.一名小儿心脏移植患者因反复感染接受粪便微生物群移植后肠道细菌微生物群组成的变化
Front Cardiovasc Med. 2017 Apr 4;4:17. doi: 10.3389/fcvm.2017.00017. eCollection 2017.
本文引用的文献
1
Development of pig welfare assessment protocol integrating animal-, environment-, and management-based measures.制定猪福利评估方案，综合考虑动物、环境和管理措施。
J Anim Sci Technol. 2015 Jan 9;57:1. doi: 10.1186/s40781-014-0034-0. eCollection 2015.
2
A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters.一种嵌合蛋白，其包含毒素B的葡糖基转移酶和半胱氨酸蛋白酶结构域以及毒素A的受体结合结构域，可诱导小鼠和仓鼠产生针对艰难梭菌感染的保护性免疫。
Hum Vaccin Immunother. 2015;11(9):2215-22. doi: 10.1080/21645515.2015.1052352. Epub 2015 Jun 2.
3
The pig gut microbial diversity: Understanding the pig gut microbial ecology through the next generation high throughput sequencing.猪肠道微生物多样性：通过下一代高通量测序了解猪肠道微生物生态
Vet Microbiol. 2015 Jun 12;177(3-4):242-51. doi: 10.1016/j.vetmic.2015.03.014. Epub 2015 Mar 23.
4
Beneficial effect of oral tigecycline treatment on Clostridium difficile infection in gnotobiotic piglets.口服替加环素治疗对悉生仔猪艰难梭菌感染的有益作用。
Antimicrob Agents Chemother. 2014 Dec;58(12):7560-4. doi: 10.1128/AAC.03447-14. Epub 2014 Sep 29.
5
Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study.克罗恩病切除时特定黏膜相关微生物群与随后疾病复发之间的关联：一项初步研究。
J Gastroenterol Hepatol. 2015 Feb;30(2):268-78. doi: 10.1111/jgh.12694.
6
A pig model of the human gastrointestinal tract.人胃肠道的猪模型。
Gut Microbes. 2013 May-Jun;4(3):193-200. doi: 10.4161/gmic.23867. Epub 2013 Apr 2.
7
Microbial shifts in the swine distal gut in response to the treatment with antimicrobial growth promoter, tylosin.猪远端肠道内微生物的变化对金霉素等抗菌促生长剂治疗的响应。
Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15485-90. doi: 10.1073/pnas.1205147109. Epub 2012 Sep 6.
8
Current strategies for management of initial Clostridium difficile infection.目前针对初次艰难梭菌感染的治疗策略。
J Hosp Med. 2012 Mar;7 Suppl 3:S5-10. doi: 10.1002/jhm.1909.
9
Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota.唾液乳杆菌 Abp118 细菌素对小鼠和猪肠道微生物群的影响。
PLoS One. 2012;7(2):e31113. doi: 10.1371/journal.pone.0031113. Epub 2012 Feb 17.
10
UCHIME improves sensitivity and speed of chimera detection.UCHIME 提高了嵌合体检测的灵敏度和速度。
Bioinformatics. 2011 Aug 15;27(16):2194-200. doi: 10.1093/bioinformatics/btr381. Epub 2011 Jun 23.
Zotero 插件